The FDA Revoked Two Monoclonal Antibody Drugs Because They Are Ineffective Against ... - Latest Tweet by PolitiFact

The FDA revoked two monoclonal antibody drugs because they are ineffective against omicron, which makes up nearly all of COVID-19 cases in the U.S. today. There are multiple other therapies that are approved that work for both delta and omicron patients. https://t.co/AzIcXnFoRc— PolitiFact (@PolitiFact) January 31, 2022

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)